Successful treatment of HIV-negative Kaposi sarcoma with ipilimumab and nivolumab and concurrent management of baseline psoriasis and bullous pemphigoid

JAAD Case Rep. 2020 Apr 30;6(5):447-449. doi: 10.1016/j.jdcr.2020.03.001. eCollection 2020 May.

Authors

Mika M Tabata¹, Robert A Novoa^{1

2}, Nam Q Bui³, Lisa C Zaba¹

Affiliations

¹ Department of Dermatology, Stanford University School of Medicine, Stanford, California.
² Department of Pathology, Stanford University School of Medicine, Stanford, California.
³ Department of Medicine-Oncology, Stanford University School of Medicine, Stanford, California.

No abstract available

Keywords: HHV-8, human herpes virus 8; HIV-negative Kaposi sarcoma; KS, Kaposi sarcoma; bullous pemphigoid; ipilimumab; nivolumab; psoriasis.

Publication types

Case Reports